Page URL:

First CRISPR law targets DIY gene therapy kits

19 August 2019
Appeared in BioNews 1011

California has passed the first-ever bill regulating genome editing technology that targets do-it-yourself CRISPR kits.

The new law, which will come into force in January 2020, requires that any genome editing kits have a clear label for consumers that says that the kit is 'not for self-administration'.

'CRISPR technology is becoming widely available to the public but many in the scientific community have sounded the alarm that it could have negative consequences outside professional labs,' says Senator Ling Ling Chang, author of the bill. 'While I'm a huge proponent of supporting scientific curiosity and imagination, I'm very concerned about the amateur use of this technology and its impact on consumer and public safety.'

DIY genome editing kits are typically designed for experiments on bacteria or yeast that allow consumers to conduct a small-scale science project at home. Some are concerned that the easy access to CRISPR via these kits could lead to consumers self-administering their experiments.

The kits are sometimes associated with a broader 'biohacking' movement, in which some amateur scientists design technological or biological human enhancements outside of traditional research institutions. The movement aims to democratise access to science, but a small number of more extreme proponents have tried using genome editing on themselves, notably Josiah Zayner who injected himself with CRISPR reagents at a conference in 2017. Zayner previously marketed a kit which used CRISPR to target a gene associated with human muscle development but has since withdrawn the kit from sale.

Since there are currently no kits for sale in California that are intended for human use, and the sale of such kits is prohibited in the United States by the FDA already, the bill has been described as 'proactive' more than addressing a current practice.

'The technology is moving faster than regulations, so it's important to be proactive about preventing safety mishaps by amateur users of CRISPR kits,' said Chang.

13 January 2020 - by Bernie Owusu-Yaw 
Promising results from clinical trials give hope for using CRISPR genome editing to treat various heritable diseases and cancer in humans...
16 December 2019 - by Ana Hallgarten 
Human Nature, directed by Adam Bolt is a documentary aimed at educating a wide audience about genome editing and the discovery and possible uses of CRISPR...
25 November 2019 - by Louisa Ghevaert 
We are currently experiencing powerful digital, artificial intelligence, genomic science, epigenetic and human reproductive revolutions. These will increasingly blur the lines between the physical, digital and biological spheres...
18 November 2019 - by Dr Jennifer Frosch 
Do-it-yourself science at home: despite my research training, this is something I have never given serious consideration...
22 July 2019 - by Georgia Everett 
A resolution to encourage international cooperation in regulating human genome editing has been introduced in the US Senate...
15 April 2019 - by Jen Willows 
Genome editing was the subject up for discussion at the Progress Educational Trust's 'Germline in the Sand' event, held at the Royal College of Physicians of Edinburgh on 19 March 2019. The discussion, which was supported by the Scottish Government sought to explore the scientific and ethical boundaries of genome editing, and what place this technology should have within our society...
18 March 2019 - by Jakki Magowan 
A group of international experts is calling for a moratorium on the clinical use of germline genome editing in humans...
10 September 2018 - by Dr Alexander Ware 
Recent programmes like Biohacking are what help Radio 4 maintain its place atop my ranking of BBC media outlets. I think I'd pay the license fee for it alone...
27 November 2017 - by Theofanis Michailidis 
The US Food and Drug Administration (FDA) is taking an active stance against the use of 'do it yourself' gene therapy kits...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.